IRIS
CLERICO, ALDO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.247
EU - Europa 33.252
AS - Asia 15.281
SA - Sud America 2.980
AF - Africa 239
Continente sconosciuto - Info sul continente non disponibili 203
OC - Oceania 25
Totale 100.227
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 47.109
GB - Regno Unito 14.443
RU - Federazione Russa 6.650
SG - Singapore 5.702
CN - Cina 4.640
UA - Ucraina 3.955
BR - Brasile 2.559
DE - Germania 2.389
IT - Italia 2.084
VN - Vietnam 2.068
HK - Hong Kong 1.603
CA - Canada 941
SE - Svezia 911
DK - Danimarca 783
FI - Finlandia 661
PL - Polonia 629
IL - Israele 266
FR - Francia 256
EU - Europa 202
IE - Irlanda 200
IN - India 186
AR - Argentina 165
BD - Bangladesh 138
MX - Messico 135
ZA - Sudafrica 114
TR - Turchia 94
IQ - Iraq 91
ID - Indonesia 90
EC - Ecuador 82
JP - Giappone 76
NL - Olanda 67
KR - Corea 53
ES - Italia 52
PK - Pakistan 51
VE - Venezuela 42
UZ - Uzbekistan 35
MA - Marocco 34
CO - Colombia 33
LT - Lituania 33
RO - Romania 32
CL - Cile 27
UY - Uruguay 27
SA - Arabia Saudita 26
AT - Austria 24
PY - Paraguay 23
KE - Kenya 21
AE - Emirati Arabi Uniti 20
JO - Giordania 20
AU - Australia 17
TN - Tunisia 16
IR - Iran 15
SK - Slovacchia (Repubblica Slovacca) 15
JM - Giamaica 13
PE - Perù 13
NP - Nepal 12
OM - Oman 12
DZ - Algeria 11
BY - Bielorussia 9
EG - Egitto 9
TT - Trinidad e Tobago 9
BH - Bahrain 8
KZ - Kazakistan 8
AL - Albania 7
AZ - Azerbaigian 7
BE - Belgio 7
CZ - Repubblica Ceca 7
DO - Repubblica Dominicana 7
ET - Etiopia 7
MY - Malesia 7
PS - Palestinian Territory 7
RS - Serbia 7
BO - Bolivia 6
LB - Libano 6
NG - Nigeria 6
NI - Nicaragua 6
NZ - Nuova Zelanda 6
PA - Panama 6
AM - Armenia 5
AO - Angola 5
CH - Svizzera 5
HN - Honduras 5
HR - Croazia 5
KW - Kuwait 5
TW - Taiwan 5
BB - Barbados 4
BG - Bulgaria 4
CI - Costa d'Avorio 4
CR - Costa Rica 4
CY - Cipro 4
SN - Senegal 4
BA - Bosnia-Erzegovina 3
KH - Cambogia 3
MD - Moldavia 3
QA - Qatar 3
SM - San Marino 3
SV - El Salvador 3
AF - Afghanistan, Repubblica islamica di 2
BN - Brunei Darussalam 2
BW - Botswana 2
GT - Guatemala 2
Totale 100.193
Salva come PNG Salva come JPEG
Città #
Southend 12.638
Dallas 8.260
Woodbridge 5.121
Ann Arbor 4.000
Chandler 3.260
Houston 3.003
Singapore 2.891
San Mateo 2.512
Beijing 2.224
Dearborn 1.956
Jacksonville 1.921
Hong Kong 1.523
Falls Church 1.474
Moscow 1.399
Fairfield 1.187
Ashburn 1.173
Seattle 1.057
Cambridge 947
Wilmington 835
Dong Ket 828
Stevenage 761
Portsmouth 693
Hefei 689
Boardman 659
Warsaw 614
Lawrence 610
Brooklyn 520
The Dalles 493
Pisa 469
Ottawa 458
Los Angeles 452
Chicago 402
São Paulo 251
Tel Aviv 248
Buffalo 241
Santa Clara 235
Ho Chi Minh City 220
Montréal 195
Dublin 186
Old Bridge 185
Salt Lake City 174
New York 165
Hanoi 137
San Diego 136
Beauharnois 107
Redwood City 101
Munich 99
Norwalk 95
Rio de Janeiro 90
Tampa 85
London 79
Johannesburg 75
Montreal 74
Elk Grove Village 70
Tokyo 69
Stockholm 66
Milan 65
Chennai 64
Rome 64
Belo Horizonte 56
Mexico City 52
Phoenix 51
Boston 48
Brasília 47
Atlanta 46
Curitiba 46
Denver 44
San Francisco 44
Guangzhou 41
Porto Alegre 41
Fremont 37
Augusta 36
Kansas City 35
Orem 35
Bologna 34
Poplar 34
Seoul 34
Toronto 34
Washington 34
Dhaka 33
Lancaster 33
Sterling 32
Haiphong 31
Tashkent 31
Ankara 30
Baghdad 30
Central District 30
Simi Valley 29
Da Nang 28
Frankfurt am Main 27
Salerno 27
Shenzhen 27
Campinas 26
Florence 26
Manchester 26
Nanjing 26
Council Bluffs 25
Helsinki 25
Nuremberg 25
Salvador 25
Totale 70.026
Salva come PNG Salva come JPEG
Nome #
N-terminal pro-B-type natriuretic peptide and high-sensitivity troponin T hold diagnostic value in cardiac amyloidosis 1.600
Valutazione delle caratteristiche analitiche e dei risultati clinici di un metodo in chemiluminescenza a cattura di microparticelle (CMIA) per il dosaggio della Galectina-3 sulla piattaforma ARCHITECT 658
[ANMCO/ELAS/SIBioC Consensus document: Recommendations for the use of cardiac biomarkers in heart failure patients] 407
siRNA-mediated targeting of endothelial VWF prevents ET-1 upregulation in porcine aortic endothelial cells chronically exposed to angiotensin II 374
Gene silencing of endothelial von Willebrand Factor attenuates angiotensin II-induced endothelin-1 expression in porcine aortic endothelial cells. 370
Downregulation of von Willebrand Factor prevents Ang II-induced endothelin-1 expression independently of eNOS activation in porcine endothelial cells 365
Comparison between BNP values measured in capillary blood samples with a POCT method and those measured in plasma venous samples with an automated platform 294
Clinical implications of a recent adjustment to the high-sensitivity cardiac troponin T assay: some results. 292
The calculation of the cardiac troponin T 99th percentile of the reference population is affected by age, gender, and population selection: A multicenter study in Italy. 290
125I-Endothelin-1 binding sites in human cardiac tissue 289
Abnormal circulating levels of muscle enzymes and myoglobin in hypothyroidism: their significance and usefulness in follow-up of replacement therapy of the metabolic disorder 288
Evaluation of analytical performance of a new high-sensitivity immunoassay for cardiac troponin i 287
State of the art of BNP and NT-proBNP immunoassays: The CardioOrmoCheck study 282
A chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using quality control sera assayed in an interlaboratory survey 281
Markers of fibrosis, inflammation, and remodeling pathways in heart failure 281
Evaluation of analytical performance and comparison of clinical results of the new generation method AccuTnI+3 for the measurement of cardiac troponin I using both patients and quality control plasma samples 274
A sensitive and accurate plasma noradrenaline assay using a modified fluorimetric method. 273
A chromatographic method for the determination of uric acid turnover in man 269
A new immunoradiometric assay for the measurement of N-terminal fragment of proatrial natriuretic peptide in human plasma: relationship with atrial and brain natriuretic peptides 266
Effect of Coronary Atherosclerosis and Myocardial Ischemia on Plasma Levels of High-Sensitivity Troponin T and NT-proBNP in Patients with Stable Angina 265
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 260
Cardiac biomarker testing in the clinical laboratory: Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides 259
A ligand-receptor binding assay of urinary and circulating endogenous digitalis-like factors 256
N-terminal prob-type natriuretic peptide is a marker of vascular remodelling and subclinical atherosclerosis in asymptomatic hypertensives 256
Diagnostic accuracy and prognostic relevance of the measurement of the cardiac natriuretic peptides: a review 253
Evaluation of the analytical performance of the advanced method for cardiac troponin I for the AxSYM platform: comparison with the old method and the Access system. 252
A chromatographic method for the determination of uric acid turnover in man 250
Natriuretic peptides as biomarkers of cardiac endocrine function in heart failure: New challenges and perspectives 250
Evaluation of analytical performance of a novel immunoenzymometric assay for cTnI. 247
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 246
Cardiac biomarker testing in the clinical laboratory:Where do we stand? General overview of the methodology with special emphasis on natriuretic peptides. 244
Comparison of Brain Natriuretic Peptide (BNP) and amino-terminal ProBNP for early diagnosis of heart failure 243
Valutazione delle caratteristiche analitiche di un nuovo metodo di dosaggio del BNP 243
Marcatori di rimodellamento e fibrosi cardiaca 242
A simplified method of measuring free triiodothyronine in serum by conbined equilibrium dialysis and gel Sephadex extraction 240
A new chemiluminescence immunoassay for CA 15-3, CA 125, CA 19-9: evaluation using QC sera assayed in an interlaboratory survey 240
A false positive case of cardiac troponin I: Which diagnostic approach? 238
Clinical relevance of non-cardiac determinants of natriuretic peptide levels. 237
Biomarkers of activation of renin-angiotensin-aldosterone system in heart failure: how useful, how feasible? 234
A simple, sensitive and rapid radioimmunoassay for measurement of urinary albumin 233
N-terminal proB-type natriuretic peptide (NT-proBNP) is superior to BNP for the detection of eraly/mild forms of heart failure 232
Evaluation of analytical performance and qualità specifications of a novel immunoenzymometric assay for cTnI: comparison with cTnI and cTnT immunoassays 232
Evaluation of reference change values for a hs-cTnI immunoassay using both plasma samples of healthy subjects and patients and quality control samples 231
Acute effects of intravenous amiodarone administration on thyroid function in arrhthmic patients 230
Acute effects of amiodarone administration on thyroid function in patients with cardiac arrhythmia 230
Direct comparison of B-Type Natriuretic Peptide (BNP) and amino-terminal proBNP in a large population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure (Val-HeFT) data 229
Acute effects of intravenous amiodarone on sulphate metabolite of thyroid hormones in arrhythmic patients 229
B-type natriuretic peptide secretion following scuba diving 228
Usefulness of High-Sensitive Troponin Elevation After Effort Stress to Unveil Vulnerable Myocardium in Patients With Heart Failure 226
Natriuretic peptides (NPs): Automated electrochemiluminescent immunoassay for N-terminal pro-BNP compared with IRMAs for ANP and BNP in heart failure patients and healthy individuals. 225
Acute effects of intravenous amiodarone on sulphate metabolites of thyroid hormones in arrhythmic patients 224
Valutazione esterna di qualità dei peptidi natriuretici BNP e NT-proBNP: risultati del programma Cardioormocheck 224
A rapid procedure for the quantization of natriuretic peptide RNAs by competitive RT-PCR in congenital heart defects 223
Analytical performance and diagnostic accuracy of a fully-automated electrochemiluminescent assay of the N-terminal fragment of brain natriuretic peptide in patients with cardiomyopathy: comparison with immunoradiometric assay methods for brain natriuretic peptide and atrial natriuretic peptide. 220
Influence of gender on circulating cardiac natriuretic hormones in patients with heart failure. 220
State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Società Italiana di Biochimica Clinica (SIBIOC). 219
Methodological assessment of mitochondrial respiratory chain-enzyme activities in cardiac tissue 217
Prognostic value of combined use of B-ype natriuretic peptides and interleukine-6 in predicting cardiac mortalità in end-stage renal disease patients 216
Rilevanza clinica e interpretazione dei marcatori biochimici nello scompenso cardiaco 216
Analytical performance and clinical results of a fully automated MEIA system for brain natriuretic peptide assay: comparison with a point of care testing method 216
Distribution of plasma cardiac troponin-I values in healthy subjects: pathophysiological considerations 215
The circulating levels of cardiac natriuretic hormones in healthy adults: effects of age and sex 214
No variation in Hsp70 mRNA level during cardiac surgery in pediatric patients evaluated by semiquantitative RT-PCR 213
The combined use of neutrophil gelatinase-associated lipocalin and brain natriuretic peptide improves risk stratification in pediatric cardiac surgery 212
N-terminal fragment of brain natriuretic peptide predicts vascular health and subclinical atherosclerosis: results from MEHLP study 212
S-nitrosoglutathione as a substrate of gamma-glutamyltransferase (GGT)- A kinetic study 210
Criteri per la valutazione delle caratteristiche analitiche e della utilità clinica dei nuovi biomarcatori cardiaci 210
Hypovitaminosis D in patients with heart failure: effects on functional capacity and patients' survival 209
Stato dell’arte dell’immunodosaggio dei peptidi natriuretici di tipo B 208
Deoxyribonucleic acid damage in human lymphocytes after percutaneous transluminal coronary angioplasty 207
Proposta per l’utilizzo in Pronto Soccorso delle troponine cardiache misurate con metodi di ultima generazione in pazienti con sospetto di sindrome coronarica acuta senza sopraslivellamento del tratto ST 206
Evaluation of the analytical performance of a new ADVIA immunoassay using the Centaur XPT platform system for the measurement of cardiac troponin i 206
Natriuretic peptide testing in primary care patients. 205
Measurement of the pro-hormone of brain type natriuretic peptide (proBNP): methodological considerations and pathophysiological relevance 204
Genomic medicine and thrombotic risk: who, when, how and why? 204
Cheyne-Stokes respiration is associated with neurohormonal activation in patients with heart failure 202
The 99th percentile of reference population for cTnI and cTnT assay: Methodology, pathophysiology and clinical implications 202
BNP values in the first days of life measured with an automated immunoassay platform 201
Prognostic complexity of heart failure and network analysis: the holistic risk stratification 200
Detection of mtDNA with 4977 bp deletion in blood cells and atherosclerotic lesions of patients with coronary artery disease. 200
Risk factors and prognostic value of daytime Cheyne-Stokes respiration in chronic heart failure patients 199
Neutrophil gelatinase-associated lipocalin (NGAL) as biomarker of acute kidney injury: a review of the laboratory characteristics and clinical evidences 199
Comparison of the diagnostic accuracy of BNP and NT-proBNP in acute and chronic heart failure. Reply Letter 198
C-type natriuretic peptide expression in patients with chronic heart failure: effects of aerobic training. 198
Cardiac troponins as biomarkers for cardiac disease 197
Heat shock protein 70-1 gene expression in pediatric heart surgery using blood cardioplegia. 196
Diagnosis of preclinical /mild heart failure with B-type natriuretic peptides: compariosn betwwen BNP and NT-proBNP immunoassay methods 196
Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review 196
Plasma gamma-glutamyltransferase fractions: diagnostic and prognostic predictive value 196
Diagnostic, prognostic and therapeutic relevance of B-type natriuretic hormone and related peptides in children with congenital heart diseases 195
B-type plasma natriuretic hormone level in operated Fallot patients 195
Evaluation of analytical performance of immunoassay methods for cTnI and cTnT: From theory to practice 195
Association between 5,10-methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and conotruncal heart defects. 194
New and emerging biomarkers of heart failure 194
New biomarkers for risk stratifications in patients with heart failure: high-sensitivity troponin I and galectin-3 194
Neuro-hormonal activation predicts ventilatory response to exercise and functional capacity in patients with heart failure. 193
Circulating levels of cardiac natriuretic peptides measured by highly sensitive and specific IRMA methods in normal subjects and in patients with heart failure 193
Gamma-glumamyl-transferase levels are associated with inflammatory activation, myocardial dysfunction and mortality in pateints with ST-elevation myocardial infarction 192
Clinical relevance of time course of BNP levels in neonates with congenital heart diseases 191
Cardiac Natriuretic Hormones, Neuro-Hormones, Thyroid Hormones and Cytokines in Normal Subjects and Patients with Heart Failure. 190
Totale 25.156
Salva come PNG Salva come JPEG
Categoria #
all - tutte 496.424
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 496.424
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20216.946 0 0 0 0 0 1.690 1.093 324 741 382 1.035 1.681
2021/20228.252 276 1.896 208 966 62 55 887 1.779 511 924 56 632
2022/20236.603 616 117 70 1.176 1.151 1.248 12 531 1.101 143 267 171
2023/20241.761 370 85 290 104 72 276 232 72 25 47 29 159
2024/202516.831 116 65 1.084 346 275 1.163 2.348 5.046 1.570 1.069 2.463 1.286
2025/202620.622 1.629 7.932 3.339 3.207 3.369 1.146 0 0 0 0 0 0
Totale 100.452